GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) » Definitions » ROCE %

Shanghai Hile Bio-Technology Co (SHSE:603718) ROCE % : -1.35% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Hile Bio-Technology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Hile Bio-Technology Co's annualized ROCE % for the quarter that ended in Mar. 2024 was -1.35%.


Shanghai Hile Bio-Technology Co ROCE % Historical Data

The historical data trend for Shanghai Hile Bio-Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Hile Bio-Technology Co ROCE % Chart

Shanghai Hile Bio-Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.32 -0.51 5.99 11.96 5.05

Shanghai Hile Bio-Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.59 24.13 -3.11 -6.45 -1.35

Shanghai Hile Bio-Technology Co ROCE % Calculation

Shanghai Hile Bio-Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=61.412/( ( (1514.253 - 320.748) + (1657.75 - 417.037) )/ 2 )
=61.412/( (1193.505+1240.713)/ 2 )
=61.412/1217.109
=5.05 %

Shanghai Hile Bio-Technology Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-16.728/( ( (1657.75 - 417.037) + (1645.166 - 398.839) )/ 2 )
=-16.728/( ( 1240.713 + 1246.327 )/ 2 )
=-16.728/1243.52
=-1.35 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Hile Bio-Technology Co  (SHSE:603718) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Shanghai Hile Bio-Technology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Hile Bio-Technology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Hile Bio-Technology Co (SHSE:603718) Business Description

Traded in Other Exchanges
N/A
Address
Shanghai Jinhai Road 6720, Shanghai, CHN, 201403
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.
Executives
Zhang Lu Director
Liu Han Ping Directors, senior managers
Zhou Yu Sheng Supervisors
Zhang Hai Ming Director
Sun Guo Bao Supervisors
Zhang Yue Director
Su Bin Director
Wu Ling Yue senior management

Shanghai Hile Bio-Technology Co (SHSE:603718) Headlines

No Headlines